ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Infectious Disease

Top Infectious Disease Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALEXANDER STEMER MD

Infectious Disease

9,105

$523K

153
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 32%

$57
Average prescription price

Avg: $222

TOM HRISOMALOS M.D.

Infectious Disease

6,361

$993K

292
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 32%

$156
Average prescription price

Avg: $222

DAFER AL-HADDADIN MD

Infectious Disease

4,917

$283K

243
195 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 32%

$57
Average prescription price

Avg: $222

DENISE WEAVER MD

Infectious Disease

3,161

$949K

223
126 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 32%

$300
Average prescription price

Avg: $222

MARJORIE DAOUD MD

Infectious Disease

2,967

$168K

184
172 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 32%

$57
Average prescription price

Avg: $222

JAMES RICHARDSON MD

Infectious Disease

2,700

$267K

268
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 32%

$99
Average prescription price

Avg: $222

DANIEL SMITH MD

Infectious Disease

2,605

$429K

353
246 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 32%

$165
Average prescription price

Avg: $222

STEVEN NORRIS MD

Infectious Disease

2,397

$1.8M

169
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 32%

$752
Average prescription price

Avg: $222

ANWER JAFFRI M.D.

Infectious Disease

2,173

$518K

190
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 32%

$238
Average prescription price

Avg: $222

MEREDITH WIERMAN D.O.

Infectious Disease

2,035

$1.68M

152
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 32%

$824
Average prescription price

Avg: $222

RODOLFO JAO M.D.

Infectious Disease

1,829

$99.9K

79
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 32%

$55
Average prescription price

Avg: $222

ROBERT BAKER MD

Infectious Disease

1,676

$727K

107
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 32%

$434
Average prescription price

Avg: $222

CRYSTAL JONES M.D.

Infectious Disease

1,599

$174K

127
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 32%

$109
Average prescription price

Avg: $222

ROBERT DEVETSKI MD

Infectious Disease

1,472

$86.6K

80
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 32%

$59
Average prescription price

Avg: $222

STEVEN BOBULA MD

Infectious Disease

1,429

$471K

143
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 32%

$330
Average prescription price

Avg: $222

APRIL MORRISON MD

Infectious Disease

970

$539K

138
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 32%

$555
Average prescription price

Avg: $222

MATTHEW MEYER MD

Infectious Disease

808

$272K

119
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 32%

$337
Average prescription price

Avg: $222

MARKIAN BOCHAN MD

Infectious Disease

774

$563K

90
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 32%

$727
Average prescription price

Avg: $222

THOMAS MEYER MD

Infectious Disease

721

$335K

109
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 32%

$465
Average prescription price

Avg: $222

ERICA YOUNG D.O.

Infectious Disease

716

$177K

146
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 32%

$247
Average prescription price

Avg: $222

DAVID COX MD

Infectious Disease

715

$298K

134
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 32%

$417
Average prescription price

Avg: $222

EMILIAN ARMEANU MD

Infectious Disease

533

$110K

118
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 32%

$207
Average prescription price

Avg: $222

JOSEPH FRAIZ MD

Infectious Disease

462

$178K

95
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 32%

$386
Average prescription price

Avg: $222

ROBERT HUNT MD

Infectious Disease

392

$36.1K

76
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

4%
prescriptions for brand name drugs

Avg: 32%

$92
Average prescription price

Avg: $222

MARY BIRCH M.D.

Infectious Disease

281

$64.2K

75
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 32%

$228
Average prescription price

Avg: $222

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank